cardiovascular risk factors in children Vol 35 No 2 51-5

diabetes and antipsychotics Vol 27 No 5 118-9

management Vol 22 No 1 12-6

management in children Vol 26 No 2 30-2

orlistat - Xenical (New drug) Vol 23 No 3 64-7

sibutramine

Medicines Safety Update Vol 33 No 3 80-3

Reductil (New drug) Vol 25 No 1 20-3

antidepressants - clinical applications Vol 22 No 5 108-11

fluvoxamine - Luvox (New drug) Vol 20 No 3 77-9

in osteoarthritis Vol 18 No 1 2-4

letter Vol 18 No 4 84-6

carbetocin - prevention of uterine atony after caesarian section - Duratocin (New drug) Vol 30 No 4 107-11

pethidine in labour pain Vol 27 No 2 34-5

Sandostatin (New strength) Vol 23 No 2 45-6

see flurbiprofen Vol 17 No 1 6-8

see ofloxacin Vol 18 No 2 35-8

treatment Vol 25 No 4 88-90

letter Vol 26 No 3 51-2

oculogyric crisis Vol 24 No 1 19-20

see trandolapril Vol 17 No 4 87-90

Aerodiol (New formulation) Vol 26 No 5 118-9

Climara 25 and 75 (New strengths) Vol 24 No 2 43-7

cyproterone combination - Climen 28 (New brand) Vol 24 No 2 43-7

Divina (New drug) Vol 18 No 3 58-9

editorial Vol 23 No 5 90-2

Estalis (New combination) Vol 23 No 5 110-1

Femtran 25 and 75 (New strength) Vol 24 No 1 20-3

Kliogest (New combination) Vol 19 No 3 81-3

Kliovance (New brand) Vol 22 No 6 147-51

new strength - Estracombi Vol 19 No 2 38-40

oestradiol valerate and cyproterone acetate - Climen (New combination) Vol 19 No 3 81-3

Sandrena (New formulation) Vol 21 No 4 108-11

hormone replacement therapy (editorial) Vol 23 No 5 90-2

medroxyprogesterone combination - Premia (New strength) Vol 24 No 6 155-8

regimens Vol 17 No 1 13-6

medroxyprogesterone combination - Premia Low (New strength) Vol 27 No 1 21-3